FDA official: Biowaiver framework needed for modified release generics
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)GenericsHealth Authority meeting and communication strategyRegulatory Intelligence/PolicyResearch, Design and DevelopmentUnited States